News in Brief
Health - Sep 16
Novartis reinforces commitment to patient access, pricing a EUR 1.85 billion sustainability-linked bond
Novartis reinforces commitment to patient access, pricing a EUR 1.85 billion sustainability-linked bond
Health - Sep 16
New Findings Recommend Patients with a Low HIV Viral Load Switch to Second-line Antiretroviral Therapy
New Findings Recommend Patients with a Low HIV Viral Load Switch to Second-line Antiretroviral Therapy
Pharmacology - Sep 16
Novartis Tafinlar + Mekinist demonstrates long-term, relapse-free survival benefit for high-risk, stage III melanoma patients in study published in NEJM
Novartis Tafinlar + Mekinist demonstrates long-term, relapse-free survival benefit for high-risk, stage III melanoma patients in study published in NEJM
wire - news in brief
Category
Results 201 - 250 of 459.
Computational pharmacology to combat the coronavirus
The ongoing COVID-19 pandemic has hit the world population hard, spreading throughout the globe since the beginning of the year and claiming more than 450,000 victims. The entire scientific community is engaged in an unprecedented effort to curb the progression of the disease, for which no specific cure is yet available.
The ongoing COVID-19 pandemic has hit the world population hard, spreading throughout the globe since the beginning of the year and claiming more than 450,000 victims. The entire scientific community is engaged in an unprecedented effort to curb the progression of the disease, for which no specific cure is yet available.
During more than 90 approaches to Zurich Airport conducted under the leadership of the Swiss SkyLab Foundation, researchers from Empa and the German Aerospace Center (DLR) tested an assistance system that supports pilots via a display during quiet and, at the same time, fuel-efficient approaches. The results show a measurable reduction in noise emissions and fuel consumption.
Particle physicists update strategy for the future of the field in Europe
Geneva, 19 June 2020. Today, the CERN Council announced that it had unanimously updated the strategy intended to guide the future of particle physics in Europe within the global landscape (the document is available here ).
Geneva, 19 June 2020. Today, the CERN Council announced that it had unanimously updated the strategy intended to guide the future of particle physics in Europe within the global landscape (the document is available here ).
In a study for the Swiss Federal Office for the Environment EPFL's International Risk Governance Center (IRGC) has brought together a group of global experts to point the way forward for international policymakers grappling with the risks and benefits posed by Carbon Dioxide Removal and Solar Radiation Modification.
If beauty is in the eye of the beholder, how do you define a beautiful landscape? Machine learning algorithms can be helpful here, says Adrienne Grêt-Regamey.
Novartis expands Africa Sickle Cell Disease program to Uganda and Tanzania
New collaborations aim to reduce the burden of sickle cell disease (SCD) in East Africa and improve access to high quality care Program continues progress in Ghana with more than 2000 patients bein
New collaborations aim to reduce the burden of sickle cell disease (SCD) in East Africa and improve access to high quality care Program continues progress in Ghana with more than 2000 patients bein
Graphene with sodium could make better batteries
Graphene doped with sodium can be a key player in making cheap batteries and spintronic devices, EPFL scientists discover.
Graphene doped with sodium can be a key player in making cheap batteries and spintronic devices, EPFL scientists discover.
Maria Schönbächler investigates how our solar system formed. Her work often reminds her of the importance of breaking out of established patterns.
Novartis Cosentyx receives FDA approval for new indication to treat active non-radiographic axial spondyloarthritis
FDA approval for Cosentyx is based on the Phase III PREVENT trial, demonstrating efficacy in active non-radiographic axial spondyloarthritis (nr-axSpA), which is part of the axial spondyloarthritis
FDA approval for Cosentyx is based on the Phase III PREVENT trial, demonstrating efficacy in active non-radiographic axial spondyloarthritis (nr-axSpA), which is part of the axial spondyloarthritis
"Huge forest fires put our health at risk"
After Australia, Siberia is burning, indicating that the frequency of such events is on the rise, with myriad dire consequences: devastated ecosystems, risk of desertification, CO2 emissions, toxic particles, further climate impacts..
After Australia, Siberia is burning, indicating that the frequency of such events is on the rise, with myriad dire consequences: devastated ecosystems, risk of desertification, CO2 emissions, toxic particles, further climate impacts..
Emiliano Albanese, MD PhD is a Full professor at the USI Faculty of Biomedical Sciences and Director of the Institute of Public Health.
Climate change, biodiversity loss, deforestation and the current pandemic crisis make it obvious. The need for a more sustainable world has never been as urgent as it is today. But how do we transition to a sustainable economy? The National Research Programme "Sustainable Economy: resource-friendly, future-oriented, innovative" (NRP 73) is creating knowledge that can support Switzerland in addressing this question.
The lockdown has been a real headache for most EPFL startups. All but a few were forced to halt their development.
How can we protect communications against "eavesdropping" if we don't trust the devices used in the process? This is one of the main questions in quantum cryptography research. Researchers at the University of Basel and ETH Zurich have succeeded in laying the theoretical groundwork for a communication protocol that guarantees one hundred percent privacy.
In a video (5'35'') combining interviews and figures, the team behind the latest collaboration from the Thomä and Schübeler labs - Alicia Michael, Ralph Grand and Luke Isbel - explain how they developed an assay identifying where the preferable sites for the transcription factor-DNA binding motif on the nucleosome were, so that they could build transcription factor-nucleosome complexes.
The fourth parabolic flight organized by the UZH Space Hub takes off today from Dübendorf airfield. A reorganization taking into account Corona safety measures has made this possible.
US FDA approves updated Novartis Beovu label, to include additional safety information
Novartis worked with US Food and Drug Administration (FDA) to update Beovu (brolucizumab) prescribing information to guide healthcare professionals in their treatment of wet AMD patients 1 The upda
Novartis worked with US Food and Drug Administration (FDA) to update Beovu (brolucizumab) prescribing information to guide healthcare professionals in their treatment of wet AMD patients 1 The upda
The French startup will use the injection of capital to ramp up marketing of a building life cycle assessment (LCA) method developed at EPFL Fribourg.
Lauzhack, or how to rescue your semester project in three days
The Lauzhack hackathon gave students a chance to redirect their semester projects towards issues related to the coronavirus.
The Lauzhack hackathon gave students a chance to redirect their semester projects towards issues related to the coronavirus.
Vanesa Rocha Martin is studying how bacteria can be used to treat infant colic. As part of her Pioneer Fellowship, she is now turning her findings into a first-line therapy with a proven effect.
Novartis PREVENT data show Cosentyx helps patients realize early and lasting relief in axial spondyloarthritis
Phase III PREVENT data show Cosentyx 150 mg provided significant and sustained improvement in signs and symptoms of non-radiographic axial spondyloarthritis (nr-axSpA) up to Week 52 1 nr-axSpA is t
Phase III PREVENT data show Cosentyx 150 mg provided significant and sustained improvement in signs and symptoms of non-radiographic axial spondyloarthritis (nr-axSpA) up to Week 52 1 nr-axSpA is t
Whether or not patients will respond to a drug can be determined in advance. In this way, side effects can be avoided and patients benefit, writes Ernst Hafen. "All things are poison, and nothing is without poison, the dosage alone makes it so a thing is not a poison." These were the words of Paracelsus, a Swiss physician who recognised back in the 16 th century that every medicine has its benefits and risks, and that for a medicine to work, the individual dose is crucial.
Systems biologist Paola Picotti receives this year's Rössler Prize for her groundbreaking work in the field of proteomics.
Parasitic wasps act as biological weapons against aphids in pest control. With the help of symbionts, however, some aphids try to defend themselves against the attacks. The struggle between these insects is one of the specialities of Christoph Vorburger, head of the "Aquatic Ecology" department and evolutionary ecologist Nina Hafer-Hahmann, postdoc in the same department.
Designing animal studies to improve research reproducibility and reduce animal use
At the invitation of the University of Bern, international experts worked out new recommendations for the design of animal studies. They encourage a paradigm shift to improve the reproducibility of scientific results and reduce animal numbers. Animal experiments are typically conducted under highly standardized laboratory conditions.
At the invitation of the University of Bern, international experts worked out new recommendations for the design of animal studies. They encourage a paradigm shift to improve the reproducibility of scientific results and reduce animal numbers. Animal experiments are typically conducted under highly standardized laboratory conditions.
EPFL researchers have modeled the effects of measures taken in the country to slow the spread of coronavirus. According to their estimates, the contamination rate has fallen by between 53% and 92%, depending on the canton, and people's movements have been reduced by 30% to 80%. Have the Swiss government's lockdown measures been effective in stemming the pandemic? That's the question a team of EPFL researchers set out to answer by analyzing data dating back to 28 February, the day the Swiss government banned groupings of over 1,000 people.
News in Brief
Health - Sep 16
Novartis reinforces commitment to patient access, pricing a EUR 1.85 billion sustainability-linked bond
Novartis reinforces commitment to patient access, pricing a EUR 1.85 billion sustainability-linked bond
Health - Sep 16
New Findings Recommend Patients with a Low HIV Viral Load Switch to Second-line Antiretroviral Therapy
New Findings Recommend Patients with a Low HIV Viral Load Switch to Second-line Antiretroviral Therapy
Pharmacology - Sep 16
Novartis Tafinlar + Mekinist demonstrates long-term, relapse-free survival benefit for high-risk, stage III melanoma patients in study published in NEJM
Novartis Tafinlar + Mekinist demonstrates long-term, relapse-free survival benefit for high-risk, stage III melanoma patients in study published in NEJM